Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration

Ischemia–reperfusion (IR) injury accelerates myocardial injury sustained during the myocardial ischemic period and thus abrogates the benefit of reperfusion therapy in patients with acute myocardial infarction. We investigated the efficacy of intracoronary ethylenediaminetetraacetic acid (EDTA) admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Donghoon, Kang, Si-Hyuck, Yoon, Chang-Hwan, Youn, Tae-Jin, Chae, In-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825805/
https://www.ncbi.nlm.nih.gov/pubmed/35136090
http://dx.doi.org/10.1038/s41598-022-05479-2